Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Other Non-Current Assets (2021 - 2023)

Intelligent Bio Solutions has reported Other Non-Current Assets over the past 3 years, most recently at $118193.0 for Q2 2023.

  • For Q2 2023, Other Non-Current Assets rose 153.62% year-over-year to $118193.0; the TTM value through Jun 2023 reached $118193.0, up 153.62%, while the annual FY2023 figure was $118193.0, 153.62% up from the prior year.
  • Other Non-Current Assets for Q2 2023 was $118193.0 at Intelligent Bio Solutions, up from $101253.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $866667.0 in Q1 2021 and troughed at $44493.0 in Q3 2022.
  • A 3-year average of $285541.0 and a median of $109723.0 in 2023 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 91.17% in 2022 and later skyrocketed 153.62% in 2023.
  • Year by year, Other Non-Current Assets stood at $504000.0 in 2021, then tumbled by 80.33% to $99120.0 in 2022, then grew by 19.24% to $118193.0 in 2023.
  • Business Quant data shows Other Non-Current Assets for INBS at $118193.0 in Q2 2023, $101253.0 in Q1 2023, and $99120.0 in Q4 2022.